ZA200909132B - 6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile derivatives as cathepsin inhibitors - Google Patents
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile derivatives as cathepsin inhibitorsInfo
- Publication number
- ZA200909132B ZA200909132B ZA200909132A ZA200909132A ZA200909132B ZA 200909132 B ZA200909132 B ZA 200909132B ZA 200909132 A ZA200909132 A ZA 200909132A ZA 200909132 A ZA200909132 A ZA 200909132A ZA 200909132 B ZA200909132 B ZA 200909132B
- Authority
- ZA
- South Africa
- Prior art keywords
- imidazo
- pyridine
- phenyl
- carbonitrile derivatives
- cathepsin inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07112517 | 2007-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200909132B true ZA200909132B (en) | 2010-08-25 |
Family
ID=38846911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200909132A ZA200909132B (en) | 2007-07-16 | 2009-12-21 | 6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile derivatives as cathepsin inhibitors |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP2178873B1 (fr) |
JP (1) | JP5371976B2 (fr) |
KR (1) | KR20100043235A (fr) |
CN (1) | CN101842373B (fr) |
AR (1) | AR067530A1 (fr) |
AT (1) | ATE492546T1 (fr) |
AU (1) | AU2008277679B2 (fr) |
BR (1) | BRPI0813587A2 (fr) |
CA (1) | CA2693887A1 (fr) |
CL (1) | CL2008002082A1 (fr) |
DE (1) | DE602008004167D1 (fr) |
EC (1) | ECSP109966A (fr) |
ES (1) | ES2356279T3 (fr) |
HK (1) | HK1142323A1 (fr) |
IL (1) | IL202769A0 (fr) |
PE (1) | PE20091087A1 (fr) |
RU (1) | RU2485119C2 (fr) |
TW (1) | TW200911803A (fr) |
WO (1) | WO2009010491A1 (fr) |
ZA (1) | ZA200909132B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7932251B2 (en) | 2007-07-16 | 2011-04-26 | N.V. Organon | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
US8026236B2 (en) | 2009-01-16 | 2011-09-27 | N.V. Organon | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
TW201035094A (en) * | 2009-01-16 | 2010-10-01 | Organon Nv | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
EP2523954B1 (fr) | 2010-01-15 | 2014-04-16 | Merck Sharp & Dohme B.V. | Dérivés de 1h-[1,2,3]triazolo[4,5-c]pyridine-4- carbonitrile comme inhibiteurs de cathepsine s |
JP5792128B2 (ja) | 2011-07-29 | 2015-10-07 | 富士フイルム株式会社 | 1,5−ナフチリジン誘導体又はその塩 |
US9328118B2 (en) * | 2012-04-17 | 2016-05-03 | Astellas Pharma Inc. | Nitrogen-containing bicyclic aromatic heterocyclic compound |
US20220193048A1 (en) | 2019-04-05 | 2022-06-23 | Universite De Bretagne Occidentale | Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning |
CA3168146A1 (fr) | 2020-01-20 | 2021-07-29 | Genzyme Corporation | Inhibiteurs therapeutiques de la tyrosine kinase pour la sclerose en plaques recurrente (rms) |
EP3858471A1 (fr) | 2020-01-31 | 2021-08-04 | Novamem AG | Production sans solvant de structures polymères poreuses |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA62972C2 (en) * | 1997-07-03 | 2004-01-15 | Application of imidazopyrimidins and imidazopyridins for the treatment of neural disorders | |
GB9921150D0 (en) * | 1999-09-07 | 1999-11-10 | Merck Sharp & Dohme | Therapeutic agents |
PA8535601A1 (es) * | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
GB0121033D0 (en) * | 2001-08-30 | 2001-10-24 | Novartis Ag | Organic compounds |
SE0201980D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
FR2852957B1 (fr) * | 2003-03-31 | 2005-06-10 | Sod Conseils Rech Applic | Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament |
EP1724264A1 (fr) * | 2004-03-10 | 2006-11-22 | Ono Pharmaceutical Co., Ltd. | Nitriles et compositions medicinales contenant ceux-ci en tant qu'ingredient actif |
TW200734338A (en) * | 2006-01-16 | 2007-09-16 | Organon Nv | 6-Phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives |
-
2008
- 2008-06-18 TW TW097122685A patent/TW200911803A/zh unknown
- 2008-07-14 CA CA2693887A patent/CA2693887A1/fr not_active Abandoned
- 2008-07-14 RU RU2010105234/04A patent/RU2485119C2/ru not_active IP Right Cessation
- 2008-07-14 BR BRPI0813587-8A2A patent/BRPI0813587A2/pt not_active Application Discontinuation
- 2008-07-14 JP JP2010516481A patent/JP5371976B2/ja not_active Expired - Fee Related
- 2008-07-14 AT AT08786128T patent/ATE492546T1/de not_active IP Right Cessation
- 2008-07-14 DE DE602008004167T patent/DE602008004167D1/de active Active
- 2008-07-14 ES ES08786128T patent/ES2356279T3/es active Active
- 2008-07-14 EP EP08786128A patent/EP2178873B1/fr active Active
- 2008-07-14 KR KR1020107003287A patent/KR20100043235A/ko not_active Application Discontinuation
- 2008-07-14 AU AU2008277679A patent/AU2008277679B2/en not_active Ceased
- 2008-07-14 WO PCT/EP2008/059172 patent/WO2009010491A1/fr active Application Filing
- 2008-07-14 CN CN200880024871XA patent/CN101842373B/zh not_active Expired - Fee Related
- 2008-07-14 PE PE2008001179A patent/PE20091087A1/es not_active Application Discontinuation
- 2008-07-14 AR ARP080103015A patent/AR067530A1/es unknown
- 2008-07-15 CL CL2008002082A patent/CL2008002082A1/es unknown
-
2009
- 2009-12-16 IL IL202769A patent/IL202769A0/en unknown
- 2009-12-21 ZA ZA200909132A patent/ZA200909132B/xx unknown
-
2010
- 2010-02-12 EC EC2010009966A patent/ECSP109966A/es unknown
- 2010-09-16 HK HK10108808.3A patent/HK1142323A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CL2008002082A1 (es) | 2009-01-02 |
RU2010105234A (ru) | 2011-08-27 |
DE602008004167D1 (en) | 2011-02-03 |
KR20100043235A (ko) | 2010-04-28 |
BRPI0813587A2 (pt) | 2014-12-30 |
CN101842373A (zh) | 2010-09-22 |
IL202769A0 (en) | 2010-06-30 |
AU2008277679B2 (en) | 2012-11-15 |
AU2008277679A1 (en) | 2009-01-22 |
CA2693887A1 (fr) | 2009-01-22 |
ES2356279T3 (es) | 2011-04-06 |
PE20091087A1 (es) | 2009-07-20 |
JP2010533675A (ja) | 2010-10-28 |
TW200911803A (en) | 2009-03-16 |
JP5371976B2 (ja) | 2013-12-18 |
WO2009010491A1 (fr) | 2009-01-22 |
ECSP109966A (es) | 2010-03-31 |
EP2178873B1 (fr) | 2010-12-22 |
RU2485119C2 (ru) | 2013-06-20 |
ATE492546T1 (de) | 2011-01-15 |
EP2178873A1 (fr) | 2010-04-28 |
CN101842373B (zh) | 2013-12-18 |
AR067530A1 (es) | 2009-10-14 |
HK1142323A1 (en) | 2010-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1142323A1 (en) | 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors | |
PL2094263T3 (pl) | Pochodne 2-adamantylo-butyroamidowe jako selektywne inhibitory 11beta-HSD1 | |
IL211148A0 (en) | 3h-imidazo [4,5-c] pyridine-6-carboxamides as anti-inflammatory agents | |
HK1138589A1 (en) | Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors | |
HK1135976A1 (en) | Pyridin-3-yl derivatives as immunomodulating agents | |
HK1105592A1 (en) | Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors | |
HK1133654A1 (en) | Pyridin-4-yl derivatives as immunomodulating agents | |
ZA200702394B (en) | Indozolone derivatives as 11b-HSD1 inhibitors | |
EP2217590A4 (fr) | Dérivés de pyridopyrimidine en tant qu'inhibiteurs de kinase p13 | |
IL198462A0 (en) | Diazepane-acetamide derivatives as selective 11??-hsd1 inhibitors | |
ZA200809800B (en) | 2-Thioxanthine derivatives acting as Mpo-inhibitors | |
HK1115321A1 (en) | Camptothecin derivatives as chemoradiosensitizing agents | |
ZA200805566B (en) | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors | |
IL195915A0 (en) | 3-amino -imidazo[1,2-a]pyridine derivatives as sglt inhibitors | |
IL196525A0 (en) | Spirocyclic azaindole derivatives | |
IL205508A0 (en) | 7 - azaindole derivatives as selective 11 - beta - hydroxysteroid dehydrogenase type 1 inhibitors | |
IL196000A0 (en) | 2-arylindole derivatives as npges-i inhibitors | |
ZA200903175B (en) | Spiro-piperidine derivatives | |
TWI339663B (en) | Spiro-piperidine derivatives | |
IL194873A0 (en) | Methods for reducing 7/9-nitrotetracycline derivatives |